PulseMedica Corp.: federal grants and contributions: 8 agreements; $1.0M value; 1 departments; 3 programs.
Assay record ASY-CA-1EO1PN20LL · Cite as: Assay Systems, “PulseMedica Corp.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/pulsemedica-corp/
The detection, tracking and treatment of vitreous floaters in human eye is currently not possible with conventional imaging and laser technology. The proposed project involves design and development of medical device prototype that is intended to be dedicated solely for the accurate detection and treatment of vitreous floaters.
PulseMedica aims to redesign and develop a more advanced medical device prototype to be used to perform more precise retinal surgery than is a current standard in medical practice. Advancements for the proprietary real-time 3D imaging and laser targeting system include enhanced image acquisition, higher speed and resolution.
PulseMedica is advancing its floater treatment system (SVO-Tx), a 3D image-guided femtosecond laser device for the non-invasive treatment of symptomatic vitreous opacities (SVOs or eye floaters). This project will complete preclinical laser safety validation, system performance verification, and assembly finalization, along with certification of two clinic-ready prototypes. It will also support development of clinical protocols and regulatory documentation in preparation for a First-in-Human (FIH) study, to follow beyond this project’s scope.
This proposed project involves development of medical device user interface and data display with a goal to supplement device with an integrated software system.
PulseMedica has developed a proprietary real-time 3D imaging and laser targeting system used for radically more precise retinal surgery. The goal of the project is to develop requirement definitions, usability analysis, concept definition, and a high-level program plan.
The Project will support development of intellectual property capacity within the Firm.
The purpose of this CanExport Innovation agreement is to support Canadian organizations to carry out activities related to pursuing opportunities that would lead to establishing new collaborative Research and Development (R&D) partnerships between the Recipient and foreign organizations in order to support R&D on the Recipient’s technology and advance its commercialization.
The project will support development of intellectual property capacity within the firm.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.